The bureaucracy blocking the chance at a cure
Summary
A Substack essay argues that early-stage clinical trials are hampered by bureaucratic barriers that inflate costs and delay potential treatments. It weaves together patient stories, entrepreneur experiences, and policy proposals to urge reforms that speed testing while maintaining safety.